{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:56:07Z","timestamp":1785858967339,"version":"3.56.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1097\/01.rli.0000174477.11541.ce","type":"journal-article","created":{"date-parts":[[2005,8,22]],"date-time":"2005-08-22T04:04:43Z","timestamp":1124683483000},"page":"614-620","source":"Crossref","is-referenced-by-count":22,"title":["Initial Computed Tomography Imaging Experience Using a New Macromolecular Iodinated Contrast Medium in Experimental Breast Cancer"],"prefix":"10.1097","volume":"40","author":[{"given":"Gerhard H.","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill","family":"Berejnoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure S.","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Lucidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Shames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Brasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210207","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2214\/ajr.137.1.141","article-title":"Perfluoroctylbromide contrast enhancement of malignant neoplasms: preliminary observations.","volume":"137","author":"Young","year":"1981","journal-title":"AJR Am J Roentgenol"},{"key":"R2-7-20210207","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00004424-198101000-00008","article-title":"Biodistribution of a particulate hepatolienographic CT contrast agent: a study of iodipamide ethyl ester in the rat.","volume":"16","author":"Violante","year":"1981","journal-title":"Invest Radiol"},{"issue":"suppl","key":"R3-7-20210207","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1097\/00004424-198011001-00038","article-title":"Particulate contrast media for computed tomographic scanning of the liver.","volume":"15","author":"Violante","year":"1980","journal-title":"Invest Radiol"},{"key":"R4-7-20210207","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3109\/10731199409138856","article-title":"The use of Imagent BP as a blood pool contrast agent to visualize and quantitate liver tumor burden.","volume":"22","author":"Steinbach","year":"1994","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"key":"R5-7-20210207","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00004424-198411000-00018","article-title":"Experimental comparison of EOE-13 and perfluoroctylbromide for the CT detection of hepatic metastases.","volume":"19","author":"Patronas","year":"1984","journal-title":"Invest Radiol"},{"key":"R6-7-20210207","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/00004424-199109000-00003","article-title":"Use of perfluorooctylbromide (PFOB) to detect liver abscesses with computed tomography. Safety and efficacy.","volume":"26","author":"Mattrey","year":"1991","journal-title":"Invest Radiol"},{"key":"R7-7-20210207","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1148\/radiology.170.1.2909094","article-title":"Potential role of perfluorooctylbromide in the detection and characterization of liver lesions with CT.","volume":"170","author":"Mattrey","year":"1989","journal-title":"Radiology"},{"key":"R8-7-20210207","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2214\/ajr.152.2.247","article-title":"Perfluorooctylbromide: a new contrast agent for CT, sonography, and MR imaging.","volume":"152","author":"Mattrey","year":"1989","journal-title":"AJR Am J Roentgenol"},{"key":"R9-7-20210207","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2214\/ajr.148.6.1259","article-title":"Perfluorochemicals as gastrointestinal contrast agents for MR imaging: preliminary studies in rats and humans.","volume":"148","author":"Mattrey","year":"1987","journal-title":"AJR Am J Roentgenol"},{"key":"R10-7-20210207","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/00004728-198408000-00028","article-title":"Perfluoroctylbromide as a blood pool contrast agent for liver, spleen, and vascular imaging in computed tomography.","volume":"8","author":"Mattrey","year":"1984","journal-title":"J Comput Assist Tomogr"},{"key":"R11-7-20210207","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00004424-198409000-00017","article-title":"Specific enhancement of intra-abdominal abscesses with perfluoroctylbromide for CT imaging.","volume":"19","author":"Mattrey","year":"1984","journal-title":"Invest Radiol"},{"key":"R12-7-20210207","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1148\/radiology.145.3.7146408","article-title":"Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography.","volume":"145","author":"Mattrey","year":"1982","journal-title":"Radiology"},{"key":"R13-7-20210207","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00004424-198005000-00011","article-title":"Experiments with radiopaque perfluorocarbon emulsions for selective opacification of organs and total body angiography.","volume":"15","author":"Long","year":"1980","journal-title":"Invest Radiol"},{"key":"R14-7-20210207","first-page":"104","article-title":"Tumor imaging with x-rays using macrophage uptake of radiopaque fluorocarbon emulsions.","volume":"84","author":"Long","year":"1978","journal-title":"Surgery"},{"key":"R15-7-20210207","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1148\/122.1.71","article-title":"Perfluoroctylbromide as a diagnostic contrast medium in gastroenterography.","volume":"122","author":"Liu","year":"1977","journal-title":"Radiology"},{"key":"R16-7-20210207","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004424-197607000-00010","article-title":"Myelography with perfluoroctylbromide. Comparison with Pantopaque.","volume":"11","author":"Liu","year":"1976","journal-title":"Invest Radiol"},{"key":"R17-7-20210207","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00004424-199608000-00006","article-title":"Ytterbium- and dysprosium-EOB-DTPA. A new prototype of liver-specific contrast agents for computed tomography.","volume":"31","author":"Krause","year":"1996","journal-title":"Invest Radiol"},{"key":"R18-7-20210207","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1076-6332(05)80834-7","article-title":"Perfluoroctyl bromide as a blood pool contrast agent for computed tomographic angiography.","volume":"1","author":"Fruman","year":"1994","journal-title":"Acad Radiol"},{"key":"R19-7-20210207","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00004728-198202000-00023","article-title":"Radiographic blood pool contrast agents for vascular and tumor imaging with projection radiography and computed tomography.","volume":"6","author":"Cassel","year":"1982","journal-title":"J Comput Assist Tomogr"},{"key":"R20-7-20210207","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1148\/radiology.170.1.2909093","article-title":"Liver, spleen, and vessels: preliminary clinical results of CT with perfluorooctylbromide.","volume":"170","author":"Bruneton","year":"1989","journal-title":"Radiology"},{"issue":"suppl 1","key":"R21-7-20210207","first-page":"S306","article-title":"Perfluoroctylbromide and hepatosplenic computed tomography. Preliminary clinical study.","volume":"23","author":"Bruneton","year":"1988","journal-title":"Invest Radiol"},{"key":"R22-7-20210207","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2214\/ajr.160.2.8424361","article-title":"Perfluorooctylbromide as a contrast agent for CT and sonography: preliminary clinical results.","volume":"160","author":"Behan","year":"1993","journal-title":"AJR Am J Roentgenol"},{"key":"R23-7-20210207","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/s-2008-1032926","article-title":"[Computed tomographic studies on density kinetics after the bolus injection and infusion of perfluorooctylbromide (PFOB). Animal experimental studies.]","volume":"156","author":"Adam","year":"1992","journal-title":"Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr"},{"key":"R24-7-20210207","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/00004424-199209000-00008","article-title":"Computed tomographic enhancement of the liver, liver abscesses, spleen, and major vessels with perfluorooctylbromide emulsion. Influence of dosage and injection velocity in an animal model.","volume":"27","author":"Adam","year":"1992","journal-title":"Invest Radiol"},{"key":"R25-7-20210207","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1148\/radiology.216.3.r00se43865","article-title":"Combined hepatocyte-selective and blood-pool contrast agents for the CT detection of experimental liver tumors in rabbits.","volume":"216","author":"Weichert","year":"2000","journal-title":"Radiology"},{"key":"R26-7-20210207","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/mrm.1910340609","article-title":"Quantification of liver blood volume: comparison of ultra short TI inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient recalled echo imaging.","volume":"34","author":"Schwickert","year":"1995","journal-title":"Magn Reson Med"},{"key":"R27-7-20210207","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1148\/radiology.198.3.8628889","article-title":"Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy.","volume":"198","author":"Schwickert","year":"1996","journal-title":"Radiology"},{"key":"R28-7-20210207","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/mrm.1910290506","article-title":"Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique.","volume":"29","author":"Shames","year":"1993","journal-title":"Magn Reson Med"},{"key":"R29-7-20210207","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s002470050296","article-title":"Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.","volume":"28","author":"Daldrup","year":"1998","journal-title":"Pediatr Radiol"},{"key":"R30-7-20210207","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1148\/radiology.198.3.8628876","article-title":"Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density.","volume":"198","author":"van Dijke","year":"1996","journal-title":"Radiology"},{"key":"R31-7-20210207","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/07357909809039771","article-title":"Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor.","volume":"16","author":"Pham","year":"1998","journal-title":"Cancer Invest"},{"key":"R32-7-20210207","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00259-002-1000-5","article-title":"MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model.","volume":"30","author":"Turetschek","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R33-7-20210207","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jps.2600830432","article-title":"Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice.","volume":"83","author":"Yamaoka","year":"1994","journal-title":"J Pharm Sci"},{"key":"R34-7-20210207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.1983.1","article-title":"Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.","volume":"3","author":"Patlak","year":"1983","journal-title":"J Cereb Blood Flow Metab"},{"key":"R35-7-20210207","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/BF00047468","article-title":"Transport of molecules across tumor vasculature.","volume":"6","author":"Jain","year":"1987","journal-title":"Cancer Metastasis Rev"},{"key":"R36-7-20210207","first-page":"191","article-title":"In vivo vascular leakage assay.","volume":"98","author":"Ferrero","year":"2004","journal-title":"Methods Mol Med"},{"key":"R37-7-20210207","first-page":"1513","article-title":"Vascular permeability in a human tumour xenograft: molecular charge dependence.","volume":"82","author":"Dellian","year":"2000","journal-title":"Br J Cancer"},{"key":"R38-7-20210207","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/mvre.1999.2207","article-title":"Different pathways of macromolecule extravasation from hyperpermeable tumor vessels.","volume":"59","author":"Feng","year":"2000","journal-title":"Microvasc Res"},{"issue":"suppl 1","key":"R39-7-20210207","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/S1076-6332(03)80413-0","article-title":"Dynamic MRI enhanced with albumin-(Gd-DTPA)30 or ultrasmall superparamagnetic iron oxide particles (NC100150 injection) for the measurement of microvessel permeability in experimental breast tumors.","volume":"9","author":"Turetschek","year":"2002","journal-title":"Acad Radiol"},{"key":"R40-7-20210207","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/153303460400300408","article-title":"Magnetic resonance imaging detects early changes in microvascular permeability in xenograft tumors after treatment with the matrix metalloprotease inhibitor Prinomastat.","volume":"3","author":"Wiart","year":"2004","journal-title":"Technol Cancer Res Treat"},{"key":"R41-7-20210207","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jmri.20049","article-title":"Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights.","volume":"20","author":"Turetschek","year":"2004","journal-title":"J Magn Reson Imaging"},{"key":"R43-7-20210207","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.rli.0000152833.35744.7f","article-title":"Contrast-enhanced computed tomography and ultrasound for the evaluation of tumor blood flow.","volume":"40","author":"Broumas","year":"2005","journal-title":"Invest Radiol"},{"key":"R44-7-20210207","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/01rli.0000124456.82985.35","article-title":"Quantitative evaluation of perfusion and permeability of peripheral tumors using contrast-enhanced computed tomography.","volume":"39","author":"Pollard","year":"2004","journal-title":"Invest Radiol"},{"key":"R45-7-20210207","first-page":"3039","article-title":"Transport of molecules in the tumor interstitium: a review.","volume":"47","author":"Jain","year":"1987","journal-title":"Cancer Res"},{"key":"R47-7-20210207","first-page":"249","article-title":"The uses and properties of PEG-linked proteins.","volume":"9","author":"Delgado","year":"1992","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"suppl 1","key":"R48-7-20210207","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/00004424-199111001-00019","article-title":"Iodinated polymer as blood-pool contrast agent. Computed tomography evaluation in rabbits.","volume":"26","author":"Revel","year":"1991","journal-title":"Invest Radiol"},{"key":"R49-7-20210207","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00004424-200101000-00006","article-title":"Preclinical profile of the monodisperse iodinated macromolecular blood pool agent P743.","volume":"36","author":"Idee","year":"2001","journal-title":"Invest Radiol"},{"key":"R50-7-20210207","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/00000539-200010000-00009","article-title":"Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers.","volume":"91","author":"Noveck","year":"2000","journal-title":"Anesth Analg"},{"key":"R51-7-20210207","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1076-6332(03)80348-3","article-title":"A molecular CT blood pool contrast agent.","volume":"9","author":"Vera","year":"2002","journal-title":"Acad Radiol"},{"key":"R52-7-20210207","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1076-6332(99)80063-4","article-title":"CT visualization of blood pool in rats by using long-circulating, iodine-containing micelles.","volume":"6","author":"Torchilin","year":"1999","journal-title":"Acad Radiol"},{"key":"R53-7-20210207","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00004424-200109000-00007","article-title":"CT pulmonary angiography with a macromolecular contrast medium: a comparative study versus iobitridol in rabbits.","volume":"36","author":"Wiart","year":"2001","journal-title":"Invest Radiol"},{"issue":"suppl 2","key":"R54-7-20210207","doi-asserted-by":"crossref","first-page":"S359","DOI":"10.1016\/S1076-6332(03)80230-1","article-title":"CT pulmonary angiography and perfusion: an experimental study using blood pool and nonspecific contrast agent.","volume":"9","author":"Berthezene","year":"2002","journal-title":"Acad Radiol"}],"container-title":["Investigative Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.rli.0000174477.11541.ce","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:59:55Z","timestamp":1785855595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004424-200509000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.rli.0000174477.11541.ce","relation":{},"ISSN":["0020-9996"],"issn-type":[{"value":"0020-9996","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}